1. Home
  2. MRVI vs CPAC Comparison

MRVI vs CPAC Comparison

Compare MRVI & CPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$5.21

Market Cap

770.0M

Sector

Health Care

ML Signal

HOLD

Logo Cementos Pacasmayo S.A.A. (Each representing five)

CPAC

Cementos Pacasmayo S.A.A. (Each representing five)

HOLD

Current Price

$12.00

Market Cap

888.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
CPAC
Founded
2014
1949
Country
United States
Peru
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
770.0M
888.7M
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
MRVI
CPAC
Price
$5.21
$12.00
Analyst Decision
Buy
Hold
Analyst Count
4
2
Target Price
$4.13
$12.90
AVG Volume (30 Days)
2.6M
66.3K
Earning Date
05-07-2026
04-24-2026
Dividend Yield
N/A
5.23%
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$12.54
$4.49
Revenue Next Year
$7.87
N/A
P/E Ratio
N/A
$19.78
Revenue Growth
N/A
N/A
52 Week Low
$1.99
$5.66
52 Week High
$5.32
$12.27

Technical Indicators

Market Signals
Indicator
MRVI
CPAC
Relative Strength Index (RSI) 67.64 84.05
Support Level $3.27 $10.30
Resistance Level N/A N/A
Average True Range (ATR) 0.25 0.29
MACD -0.01 0.19
Stochastic Oscillator 81.45 100.00

Price Performance

Historical Comparison
MRVI
CPAC

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About CPAC Cementos Pacasmayo S.A.A. (Each representing five)

Cementos Pacasmayo SAA is a Peruvian cement company, and only cement manufacturer serving in the northern region of Peru. It produce, distribute and sell cement and cement-related materials, such as precast products and ready-mix concrete. Its products are mainly used in construction, which has been one of the fastest growing segments of the Peruvian economy in recent years. It also produce and sell quicklime for use in mining operations. It also provide transportation services. It has three operating segments cement, concrete, mortar, pavement and precast; quicklime; and sales of construction supplies. The majority of profit comes from Cement segment. Peru's cement production is into three regions northern region, central region, including Lima's metropolitan area, and southern region.

Share on Social Networks: